Deignan Charles A. 4
4 · Clearside Biomedical, Inc. · Filed Sep 13, 2023
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-09-13$0.40/sh+34,090$13,636→ 397,562 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-09-13−34,090→ 0 totalExercise: $0.40Exp: 2023-11-24→ Common Stock (34,090 underlying)
Footnotes (1)
- [F1]Fully vested and exercisable.